Zenas Biopharma Inc

ZBIONASDAQ NMS - GLOBAL MARKET

Health CareBiotechnology

$18.40

-0.160000 (-0.86%)

As of 05/29/26 EDT · USD

Compare

52-Week Low: $8.91Current: $18.4052-Week High: $44.60

Key Statistics

Open

$18.56

Day High

$19.00

Day Low

$18.14

Prev. Close

$18.56

Volume

658.56K

Avg. Volume

—

Market Cap

$1.16B

P/E (TTM)

-2.18

Forward P/E

—

P/B Ratio

—

52W High

$44.60

52W Low

$8.91

50D MA

$20.01

200D MA

$24.58

Dividend Yield

—

Beta

—

Performance

-7.3%

+4.8%

-53.8%

YTD

-46.7%

+82.9%

About

Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban (Eliquis) for people with atrial fibrillation ; nivolumab (Opdivo), used to treat certain types of cancer ; lenalidomide (Revlimid), used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes ; abatacept (Orencia), used to treat autoimmune diseases such as rheumatoid arthritis ; pomalidomide (Pomalyst/Imnovid), an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma ; ipilimumab (Yervoy), to treat cancer ; and luspatercept (Reblozyl) for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.

zenasbio.com/